# A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

> **NCT01068301** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 12 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
- Myelodysplastic Syndrome
- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT01068301
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-01-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068301, "A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01068301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*